Literature DB >> 8719474

Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.

S Aziz1, T O McDonald, H Gohra.   

Abstract

With use of this straight artery model of transplantation for studying TGVD, we have shown the following: 1. Intimal thickening occurs in a time-dependent predictable manner only in allografts. 2. Endothelial injury as a result of procurement, preservation, and reperfusion by itself does not result in the development of intimal thickening. Additional endothelial injury associated with the presence of an early mononuclear infiltrate is necessary for the development of TGVD. 3. The development of intimal hyperplasia is initially cellular, consisting mainly of macrophages and a smaller proportion of lymphocytes. The macrophages are later replaced by SMCs. These findings are summarized in Figure 16. 4. The source of the SMCs in intimal lesions is most likely the recipient media.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719474

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection.

Authors:  J F Légaré; T Issekutz; T D Lee; G Hirsch
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

Authors:  L L Shears; N Kawaharada; E Tzeng; T R Billiar; S C Watkins; I Kovesdi; A Lizonova; S M Pham
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice.

Authors:  J Li; X Han; J Jiang; R Zhong; G M Williams; J G Pickering; L H Chow
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.

Authors:  J L Hillebrands; F A Klatter; B M van den Hurk; E R Popa; P Nieuwenhuis; J Rozing
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.